Dr. Damien Kenny:

If I can come back in there, one of the things about which there may have been concerns is performing an in vitrodiagnostic outside a standard laboratory setting. We are not talking about selling this or providing it for the person on the street. We are talking about performing testing outside a standard laboratory setting but in a controlled environment using fully-trained personnel. As I alluded to, there are multiple examples of in vitrodiagnostics having moved beyond the lab. The concept of point-of-care molecular testing is really going to be vital for the healthcare system moving forward. With antibiotic resistance, there are a number of accounts of where lab-based in vitrodiagnostics are accurate but slow and cumbersome. We need something that is rapid and mobile to provide rapid diagnostic testing to be able to identify persons who are asymptomatic but carrying virus.